This page lists the portfolio holdings of Charles K. Bobrinskoy.
Stock Holdings
Charles K. Bobrinskoy - Ariel Focus
Period: Q2 2010
Portfolio date: 30 Jun 2010
No. of stocks: 23
Portfolio value: $47,975,000
| Symbol | Stock | % of portfolio | Shares | Recent activity | |
| JNJ | hist | Johnson & Johnson | 6.38 | 51,800 | Add 48.00% |
| HEW | hist | Hewitt Associates Inc. | 5.61 | 78,100 | Add 79.95% |
| IBM | hist | International Bus. Machines | 5.40 | 21,000 | Add 40.94% |
| MRK | hist | Merck & Co. | 5.17 | 70,900 | Add 58.26% |
| XOM | hist | Exxon Mobil Corp. | 5.00 | 42,000 | Add 59.70% |
| TYC | hist | Tyco International | 4.79 | 65,275 | Add 26.32% |
| OMC | hist | Omnicom Group | 4.75 | 66,400 | Add 20.73% |
| LMT | hist | Lockheed Martin Corp. | 4.46 | 28,700 | Add 42.79% |
| DELL | hist | Dell Inc. | 4.45 | 176,900 | Add 42.66% |
| MS | hist | Morgan Stanley | 4.44 | 91,750 | Add 44.60% |
| DIS | hist | Walt Disney Co. | 4.35 | 66,300 | Add 27.75% |
| BAX | hist | Baxter International Inc. | 4.25 | 50,200 | Add 148.51% |
| BK | hist | Bank of New York | 4.22 | 82,000 | Add 40.89% |
| APOL | hist | Apollo Group | 4.04 | 45,600 | Add 42.50% |
| ACN | hist | Accenture | 4.03 | 50,000 | Add 2.67% |
| JPM | hist | JPMorgan Chase & Co. | 3.84 | 50,300 | Add 68.23% |
| IPG | hist | Interpublic Group | 3.84 | 258,400 | Add 41.13% |
| AFL | hist | AFLAC Inc. | 3.82 | 42,900 | Add 18.84% |
| HES | hist | Hess Corp. | 3.82 | 36,400 | Add 41.63% |
| COV | hist | Covidien Plc. | 3.74 | 44,675 | Add 41.94% |
| CCL | hist | Carnival Corp. | 3.69 | 58,500 | Add 43.03% |
| TM | hist | Toyota Motor Corp. | 3.30 | 23,100 | Add 44.38% |
| GS | hist | Goldman Sachs Group | 2.63 | 9,600 | Buy |
Sector % analysis
| Consumer Discretionary | |
| Health Care | |
| Financials | |
| Information Technology | |
| Services | |
| Industrials | |
| Energy | |
| Consumer Goods |
Articles & Commentaries
24 Aug 2010 Video: Charles Bobrinskoy on Bloomberg
Ariel's Bobrinskoy Is `Worried' About Bond Market Bubble - thinks high quality large cap stocks are very cheap...
Ariel's Bobrinskoy Is `Worried' About Bond Market Bubble - thinks high quality large cap stocks are very cheap...
12 Aug 2010 Video: Charles Bobrinskoy on Bloomberg
Charles Bobrinskoy of Ariel Investments talks about Federal Reserve policy and the U.S. stock market...
Charles Bobrinskoy of Ariel Investments talks about Federal Reserve policy and the U.S. stock market...
01 Jul 2010 Video: Charlie Bobrinskoy on CNBC
Charlie Bobrinskoy of Ariel Investments on Apollo's Q3 results...
Charlie Bobrinskoy of Ariel Investments on Apollo's Q3 results...
29 Jun 2010 Video: Charles Bobrinskoy on Bloomberg
Charles Bobrinskoy, director of research for Ariel Investments, speaks about the stock market and investment strategy in health-care stocks...
Charles Bobrinskoy, director of research for Ariel Investments, speaks about the stock market and investment strategy in health-care stocks...
13 Apr 2010 Video: Ariel's Bobrinskoy Interview About U.S. Stock Market
Bloomberg - Charles Bobrinskoy, director of research at Ariel Investments thinks stocks are still good value long term...
Bloomberg - Charles Bobrinskoy, director of research at Ariel Investments thinks stocks are still good value long term...
24 Mar 2010 Video: Charles Bobrinskoy on Bloomberg
Charles Bobrinskoy, director of research at Ariel Investments, talks with Bloomberg's Matt Miller and Carol Massar about the likely impact of the U.S. healthcare bill on financial markets and healthcare companies...
Charles Bobrinskoy, director of research at Ariel Investments, talks with Bloomberg's Matt Miller and Carol Massar about the likely impact of the U.S. healthcare bill on financial markets and healthcare companies...
17 Dec 2009 Ariel Investments - Portfolio Company Spotlights
Companies discussed: Covidien plc, Newell Rubbermaid and Viacom.
Companies discussed: Covidien plc, Newell Rubbermaid and Viacom.
30 Nov 2009 Video: Charles Bobrinskoy on Bloomberg
Charles Bobrinskoy of Ariel Investments recommends quality stocks, health care...
Charles Bobrinskoy of Ariel Investments recommends quality stocks, health care...
20 Nov 2009 Ariel Focus Fund - Q3 2009 Commentary
Some of the best companies in the world are trading at some of the best values we have seen in the last 20 years.
You might have thought these stocks would have done well lately, when investors have flocked to safer assets like money market funds and treasury bills. And yet, they have trailed the market badly and are trading at extremely low valuations compared to historical norms. Despite their industry leadership, the seven industry leaders’ stocks have trailed the S&P 500 Index by an average of I9.7% year-to-date. Four of the seven (P&G, Exxon, McDonald’s and Wal-Mart) have actually seen their stock prices fall this year. Only Toyota, a long-term holding in the Fund, has slightly outperformed the broad market helped by the strong yen.
But just because the stocks of high quality companies have underperformed the market does not mean these stocks represent good opportunities today—that depends on how these companies are being valued. At quarter-end, the Fund’s second largest position was Johnson & Johnson. As a company, Johnson & Johnson’s long-term performance has been spectacular. Over the last 20 years, J&J’s earnings have grown at a remarkably steady rate from $0.40 then to $4.50 today. And we estimate J&J’s earnings will continue to grow to $4.92 in 2010 and $5.39 in 2011, propelled by wonderful brands like Listerine® and Tylenol® and increasing demand for its med-tech products like artificial hips and knees. You might think the market would reward this steady growth with a high PE multiple. But at quarter end, J&J traded at only 12.7x forward earnings, two full multiple points below the broad market and seven multiple points below J&J’s 17-year average of 19.7x.
As we are fond of repeating, the last time J&J traded at this low a multiple was in 1994 when health care reform was being debated during the Clinton administration. During the next five years, from 1994 through 1999, J&J’s stock increased from $10 to $50, outperforming the S&P 500 Index by more than +200%.
Some of the best companies in the world are trading at some of the best values we have seen in the last 20 years.
You might have thought these stocks would have done well lately, when investors have flocked to safer assets like money market funds and treasury bills. And yet, they have trailed the market badly and are trading at extremely low valuations compared to historical norms. Despite their industry leadership, the seven industry leaders’ stocks have trailed the S&P 500 Index by an average of I9.7% year-to-date. Four of the seven (P&G, Exxon, McDonald’s and Wal-Mart) have actually seen their stock prices fall this year. Only Toyota, a long-term holding in the Fund, has slightly outperformed the broad market helped by the strong yen.
But just because the stocks of high quality companies have underperformed the market does not mean these stocks represent good opportunities today—that depends on how these companies are being valued. At quarter-end, the Fund’s second largest position was Johnson & Johnson. As a company, Johnson & Johnson’s long-term performance has been spectacular. Over the last 20 years, J&J’s earnings have grown at a remarkably steady rate from $0.40 then to $4.50 today. And we estimate J&J’s earnings will continue to grow to $4.92 in 2010 and $5.39 in 2011, propelled by wonderful brands like Listerine® and Tylenol® and increasing demand for its med-tech products like artificial hips and knees. You might think the market would reward this steady growth with a high PE multiple. But at quarter end, J&J traded at only 12.7x forward earnings, two full multiple points below the broad market and seven multiple points below J&J’s 17-year average of 19.7x.
As we are fond of repeating, the last time J&J traded at this low a multiple was in 1994 when health care reform was being debated during the Clinton administration. During the next five years, from 1994 through 1999, J&J’s stock increased from $10 to $50, outperforming the S&P 500 Index by more than +200%.
19 Nov 2009 Video: Ariel Fund's Charles Bobrinskoy on Bloomberg
Value investor Charles Bobrinskoy of Ariel Funds believes stocks are still cheap especially in healthcare - also likes JP Morgan...
Value investor Charles Bobrinskoy of Ariel Funds believes stocks are still cheap especially in healthcare - also likes JP Morgan...
08 Jun 2009 Video: Charles Bobrinskoy, vice chairman of Ariel Investments on Bloomberg
Likes Aflac, JPMorgan and Disney
Likes Aflac, JPMorgan and Disney
13 Feb 2009 Video: Charles Bobrinskoy of Ariel Investments
Charles Bobrinskoy of Ariel Investments has gone scavenging in Wall Street's trash can - recommends Dell and Aflac ...
Charles Bobrinskoy of Ariel Investments has gone scavenging in Wall Street's trash can - recommends Dell and Aflac ...